Founded in 2001 in the United States, Title21 is an enterprise software company providing FDA-regulated solutions to Cell Therapy labs in hospitals. Its main product offerings are Electronic Quality Management System (EQMS) and Cell Therapy Solutions (BMT / CT): EQMS provides a scalable solution to automate workflows, integrate compliance-driven processes, and enable continuous quality improvement. BMT/CT enables end-to-end electronic management of cellular therapy processes across clinical, manufacturing, and post-infusion followup. Title21 is one of few Cell Therapy software businesses tracking all three supply chains: custody, identity and condition.